Ultralife Corporation (FRA:ULB)

Ultralife Statistics

Total Valuation

Ultralife has a market cap or net worth of EUR 79.63 million. The enterprise value is 118.09 million.

Market Cap	79.63M
Enterprise Value	118.09M

Important Dates

The last earnings date was Tuesday, November 18, 2025.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	16.65M
Shares Outstanding	n/a
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	37.03%
Owned by Institutions (%)	37.93%
Float	10.48M

Valuation Ratios

The trailing PE ratio is 54.38.

PE Ratio	54.38
Forward PE	n/a
PS Ratio	0.50
PB Ratio	0.68
P/TBV Ratio	1.36
P/FCF Ratio	10.44
P/OCF Ratio	7.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.00, with an EV/FCF ratio of 15.48.

EV / Earnings	80.65
EV / Sales	0.74
EV / EBITDA	10.00
EV / EBIT	19.50
EV / FCF	15.48

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.39.

Current Ratio	2.99
Quick Ratio	1.19
Debt / Equity	0.39
Debt / EBITDA	3.92
Debt / FCF	6.01
Interest Coverage	1.83

Financial Efficiency

Return on equity (ROE) is 1.28% and return on invested capital (ROIC) is 2.60%.

Return on Equity (ROE)	1.28%
Return on Assets (ROA)	2.23%
Return on Invested Capital (ROIC)	2.60%
Return on Capital Employed (ROCE)	3.73%
Revenue Per Employee	236,929
Profits Per Employee	2,182
Employee Count	671
Asset Turnover	0.95
Inventory Turnover	2.93

Taxes

In the past 12 months, Ultralife has paid 484,106 in taxes.

Income Tax	484,106
Effective Tax Rate	24.66%

Stock Price Statistics

The stock price has decreased by -30.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-30.16%
50-Day Moving Average	5.46
200-Day Moving Average	5.66
Relative Strength Index (RSI)	41.61
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.99

Income Statement

In the last 12 months, Ultralife had revenue of EUR 158.98 million and earned 1.46 million in profits. Earnings per share was 0.09.

Revenue	158.98M
Gross Profit	37.98M
Operating Income	6.00M
Pretax Income	1.96M
Net Income	1.46M
EBITDA	10.58M
EBIT	6.00M
Earnings Per Share (EPS)	0.09

Balance Sheet

The company has 7.89 million in cash and 45.85 million in debt, giving a net cash position of -37.96 million.

Cash & Cash Equivalents	7.89M
Total Debt	45.85M
Net Cash	-37.96M
Net Cash Per Share	n/a
Equity (Book Value)	117.13M
Book Value Per Share	7.03
Working Capital	57.04M

Cash Flow

In the last 12 months, operating cash flow was 10.69 million and capital expenditures -3.06 million, giving a free cash flow of 7.63 million.

Operating Cash Flow	10.69M
Capital Expenditures	-3.06M
Free Cash Flow	7.63M
FCF Per Share	n/a

Margins

Gross margin is 23.89%, with operating and profit margins of 3.77% and 0.92%.

Gross Margin	23.89%
Operating Margin	3.77%
Pretax Margin	1.23%
Profit Margin	0.92%
EBITDA Margin	6.65%
EBIT Margin	3.77%
FCF Margin	4.80%

Dividends & Yields

Ultralife does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	-0.50%
Earnings Yield	1.84%
FCF Yield	9.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ultralife has an Altman Z-Score of 1.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.94
Piotroski F-Score	4